Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Kringle Pharma, Inc. ( (JP:4884) ).
Kringle Pharma, Inc. reported its financial results for the fiscal year ending September 30, 2025, showing a decline in net sales and increased losses compared to the previous year. The company’s financial position weakened with reduced total assets and net assets, impacting its equity ratio and cash flows, which may affect its operational strategies and stakeholder confidence.
More about Kringle Pharma, Inc.
Kringle Pharma, Inc. is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical industry. The company focuses on developing innovative therapies and has a market focus on advancing healthcare solutions.
Average Trading Volume: 79,729
Technical Sentiment Signal: Sell
Current Market Cap: Yen3.07B
For an in-depth examination of 4884 stock, go to TipRanks’ Overview page.